Former DEA officials are challenging the federal rescheduling process.
They cite concerns over regulatory safeguards: a move that could shift the timeline.
The June 29 hearing is the next flashpoint.
Stay informed on the legal battle.
--> https://t.co/2TSBrqeRji
Virginia reaches a watershed moment.
Bipartisan deal secured: July 1, 2027 launch.
A major compromise after years of vetoes.
350-store cap.
6% tax rate.
Industry progress in the Commonwealth.
--> https://t.co/2TSBrqeRji
The clock is ticking for cannabis operators.
June 22: the deadline is here.
State-licensed medical businesses must apply for DEA registration under the Schedule III order.
Don’t get left behind. Compliance is mandatory.
--> https://t.co/2TSBrqeRji
Texas is dropping the hammer.
Court-approved fee hikes: from $250 up to $10,000.
Small businesses are being taxed out of the hemp industry.
A watershed moment for Texas entrepreneurs.
Don't get left behind.
Stay informed with Cannabis Radio.
--> https://t.co/ru07cg4RRW
The rescheduling process is hitting a wall.
NDASA and MMJ International are pushing for a federal stay.
High stakes: 280E relief and the move to Schedule III could be frozen indefinitely.
Are you prepared for the pause?
Get the full breakdown:
--> https://t.co/ru07cg4RRW
Wall Street history. Trulieve (TRLV) hits the NYSE; a watershed moment for U.S. cannabis. Normalization isn't a goal: it’s reality. Schedule III validation in action. Stay ahead of the curve. --> https://t.co/wfgp0knvCy
The clock is ticking.
Medical operators: you have 11 days to file for DEA Schedule III registration.
Deadline: June 22.
Secure your continuity protection before it's too late.
--> Stay compliant at https://t.co/ru07cg4RRW
NY’s 5-year lesson? Red tape fuels the gray market. 🍎
High barriers don't protect the public: they empower illicit shops. To win, regulators must slash bureaucracy and let the legal market breathe.
Expert analysis on Blunt Business.
--> https://t.co/ru07cg4RRW
Psychedelic research is hitting the fast-track.
While cannabis stalls in federal limbo, MDMA therapy for veterans is gaining massive momentum.
Breakthrough status vs. Schedule I hurdles. What's next?
Hear the data on Psychedelic Radio.
--> https://t.co/ru07cg4RRW
Don't leave your money on the table. 🏦
The 3-year statute of limitations for 280E protective claims is ticking. If you paid taxes in 2023–2025, you need a strategy now.
Secure your retroactive relief before the window closes.
Learn how --> https://t.co/ru07cg4RRW
The era of high-potency is fading.
Biohacking is the new standard.
The "Ozempic effect" is reshaping metabolic health; forcing a strategic pivot toward microdosing for longevity.
The industry is evolving. Are you keeping up?
Listen at:
--> https://t.co/wfgp0knvCy
The clock is ticking. ⏳
Medical operators have 20 days; deadline June 22; to file for DEA Schedule III registration.
Miss this window? You miss continuity protection. This is the critical hurdle for the medical sector.
Don't be left behind.
--> https://t.co/ru07cg4RRW
FDA Priority Review Vouchers are a game-changer for psychedelic biotech.
A technical win that slashes time-to-market : and boosts investment ROI.
Startups are pivoting. Capital is flowing.
Don’t get left behind.
Learn the strategy --> https://t.co/ru07cg4RRW
Flower is losing its crown.
2026 data is clear; vapes and pre-rolls now dominate the market.
Convenience beats the ritual.
A watershed moment for craft growers: pivot or get left behind.
Get the breakdown.
--> https://t.co/ru07cg4RRW
Louisiana is rewriting the playbook.
Opioid settlement funds are fueling psychedelic research; a strategic workaround for federal funding gaps.
This isn’t just policy. It’s a watershed moment for plant medicine.
--> Search ‘Cannabis Radio’ on your app.
280E is the $15B anchor dragging down your business.
7 House Democrats are now demanding "prompt" IRS guidance for relief.
You’re stuck in tax limbo while the clock ticks.
Will the IRS deliver before the next cycle?
Stay ahead of the curve.
--> https://t.co/ru07cg4RRW
Oklahoma is leading the addiction breakthrough charge.
The Heartland is betting on Ibogaine; and it’s moving fast.
Is this state-led movement outpacing psilocybin?
Industry pros: Don’t miss this watershed moment.
Listen now:
--> https://t.co/ru07cg4RRW
The DOJ's rescheduling order is under fire. ⚖️
Nebraska, Indiana, and Louisiana have drawn the legal battle lines.
Briefing deadlines hit this week.
Political theater or a genuine industry threat?
Get the full breakdown on the network.
--> https://t.co/ru07cg4RRW
The $15B question: Can the cannabis industry finally breathe after 280E relief? 🌿
Beau Whitney breaks down the ripple effects on Blunt Business.
Listen: https://t.co/iDbS9rqzJx